ELECT 24 Top Ad

Options Traders Win with SAGE, CLVS Stock Surges

It's been a busy day in the healthcare sector

Jan 7, 2019 at 2:15 PM
facebook X logo linkedin


The healthcare sector is in focus today, most notably due to Eli Lilly's (LLY) plans to buy Loxo Oncology (LOXO) for $8 billion and the J.P. Morgan Healthcare Conference. A couple other names also making big moves are Clovis Oncology Inc (NASDAQ:CLVS) and SAGE Therapeutics Inc (NASDAQ:SAGE), with shares of both CLVS and SAGE surging on upbeat drug buzz. What's more, these gains could be good news for recent options traders.

This morning Clovis Oncology revealed how much money it made from its drugs in 2018 and Wall Street is cheering the numbers. The main highlight was the company's cancer drug Rubraca is expected to bring in between $95.3 and $95.8 million for the year. Fanning the bullish flames was a note out of Leerink that called out CLVS as a potential winner from the Eli Lilly-Loxo Oncology deal.

CLVS stock was last seen trading up 18.7% at $21.76, but the 80-day moving average could be putting a lid on the rally. Even with these gains, the shares' remain in a sharp downtrend for the past 52 weeks, losing almost 68% during the time. Analysts have remained bullish on the security, with seven of nine in coverage recommending to buy it.

Meanwhile, options traders may be profiting from today's price action. Data from the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) shows a 10-day call/put volume ratio of 19.54 that ranks in the 85th annual percentile, meaning there was unusual demand for long call options.

SAGE stock is also exploding higher today, trading up 41% at $137.46, briefly topping its 200-day moving average for the first time since early September. This comes after the company said its postpartum depression treatment met its main goals in a late-stage trial.

Bullish bettors at the ISE, CBOE, and PHLX had also been targeting SAGE Therapeutics. The 10-day call/put volume ratio across these exchanges comes in at 4.46 for the security, good enough for the 73rd annual percentile.

 

Biden’s government just announced a new government "stimulus program"...

And it could hand you a payment for as much as $7,882 — each quarter.

See, it has to do with a recent 19-page memo from Biden’s office...

Directing the government to once again send a form of "stimulus payments" to the mailboxes of Americans during these difficult times.

Better still, you can collect these payouts every single quarter — for life...

Payments run as high as $7,882... And it only takes five minutes to sign up.

I call this the "Stimulus Stipends" program…

And Forbes recently declared that you can "retire rich" thanks to this program.

So if you want to start cashing in your quarterly payouts — courtesy of the U.S government...

Discover how to receive your FIRST "Stimulus Stipends" payment for up to $7,882 here. 
 (ad)
 

election 2024 report

                                                  AD                                                  
best AI trade you can make today…?
(it’s not MSFT, GOOGL, AMZN or AAPL)

                                                  AD                                                  

 
 

VOLATILITY SCORECARD

 


                                               AD                                                    
Crazy Opportunity!! Tiny AI Stock just $3
“This Type of AI Will Be Worth “Ten MSFTs.”

                                               AD                                                    

 
4 AI STOCKS TO BUY NOW
 

                                                  AD                                                  
best AI trade you can make today…?
(it’s not MSFT, GOOGL, AMZN or AAPL)

                                                  AD